Intellia Therapeutics
Intellia Therapeutics is a biotechnology company founded in 2014, based in Cambridge, MA that develops biopharmaceuticals using CRISPR-Cas9 gene editing technology.
Key facts
| AngelList URL | https://angel.co/intellia-therapeutics-2 |
|---|---|
| Legal Name | Intellia Therapeutics, Inc. |
| Company Operating Status | Active |
| Crunchbase URL | https://www.crunchbase.com/organization/intellia-therapeutics |
| Facebook URL | https://www.facebook.com/pages/Intellia-Therapeutics/133289660562078 |
| Full Address | 40 Erie Street Cambridge, MA 02139 United States |
| Instagram URL | https://www.instagram.com/intellia_therapeutics/ |
| LinkedIn URL | https://www.linkedin.com/company/intellia-therapeutics-inc-/ |
| Pitchbook URL | https://pitchbook.com/profiles/company/99583-30#overview |
| Stock Symbol | NTLA |
| Twitter URL | https://twitter.com/intelliatweets |
| Official Website | https://intelliatx.com |
| Wellfound ID | intellia-therapeutics-2 |
| Wikidata ID | Q54621387 |